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In the area of regenerative medicine, researchers have
been exploring the potential of Stem Cells in preclinical
and clinical studies to improve therapies that can resolve
injuries by enhancing endogenous repair, opening a new
paradigm in cell therapy.Stem cells may it be embryonic
stem cells (ESC), induced pluripotent stem cells (iPSC)
or adult stem cells have been used as potential sources
for beta cell replacement therapy across the globe.
Numerous studies have shown the differentiation poten-
tial of ESCs and iPSCs towards producing pancreatic
progenitors but after terminal differentiation into insulin
producing cells these lacked various important pancrea-
tic markers and have low index of glucose stimulated
insulin secretion (GSIS). This along with other ethical
conundrums makes it difficult to use ESCs as a source
for cell therapy. Adult stem cells provide clinically and
ethically accepted option over embryonic or induced
pluripotent stem cells, as they can be used as autologous
source for cell transplant in treatment of diabetes.
Widely used option of cadaveric islet therapy has its
own problems due to insufficient amount of islets avail-
able for transplantation. Hence, our research is focused
on increasing islet mass from various adult stem cells
using neutraceutic bioactive compounds isolated from a
plant demonstrating efficient anti-diabetic activity and
further explored them as potent differentiating agent
under in-vitro and in-vivo condition. In-vitro differen-
tiated islets from various adult stem cells sources were
assessed at morphological, molecular, immunological
and functional level and further evaluated for glucose
lowering effect after transplantation in Streptozotocin
(STZ) induced diabetic balb/c mice.
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